logical development of solid dispersions. The parameters like manufacturing certain thermodynamic properties of BCS class II drugs, factors that affects stability of the system, physicochemical properties of drug in…
most challenging in formulation development. Due to poor aqueous solubility of BCS Class II result in the poor oral bioavailability makes drug formulation development more difficult. Hence, various approaches have…
this study is to change the solubility of poorly- water soluble, BCS Class-II drug Aceclofenac via SD technique. Aceclofenac is a non-steroidal anti-inflammatory drug (NSAID) having both
with minimum gastric effects and improved dissolution rate for aceclofenac (ACF), a model BCS class-II drug. Methods: Self-emulsifying drug delivery systems (SEDDS) were formulated to increase the solubility ... oral…
hormonally positive breast cancer in postmenopausal women. Letrozole is categorized as a BCS class II drug. It has poor water solubility, rapid metabolism and a range of side effects. Objective
hormonally positive breast cancer in postmenopausal women. Letrozole is categorized as a BCS class II drug. It has poor water solubility, rapid metabolism and a range of side effects. Objective
which has been proven as a promising tool to enhance the solubility of BCS class II drugs and improve drug permeation rate through the skin. The formulation contains the drug
ailments such as Arthritis and Dysmonorrhoea. It is considered to be a BCS Class II drug (low soluble and high permeable). Mefenamic acid has less biological life
develop a topical nanoemulgel of a BCS class II drug, Glimepiride (GLP) in both and inclusion complexed form. In our previous studies, we prepared binary and ternary inclusion complexes
selected as a model drug for research work, because it belongs to BCS class –II which has low solubility and high permeability. Furthermore it is unprotected to enzymatic degradation
prepare etodolac (ETD), the NSAID drug compound which is Biopharmaceutical Classification System (BCS) Class II drug with low solubility and high permeability, nanosuspensions using wet ball grinding method
Febuxostat which is a BCS class II anti-Gout drug was prepared into Solid Dispersion to increase its solubility. FDT is a dosage form that disintegrates instantly when placed
salt formation, complexation, solid dispersion etc. Hydrochlorothiazide (HCT) is one of the BCS class II drug having poor water solubility. Thus to increase its water solubility by solid dispersion technique
modified starch. As per FDA guidelines on biowaivers, drug products containing weakly acidic BCS class II drugs with a dissolution of > 85% in 30 min are eligible for biowaiver. Hence
development of new dosage form and shows poor bioavailability. The drugs belong to BCS class II has problem of solubility, to overcome the solubility problem nanotechnology is most useful technique
system of stable dispersions exploitation BCS class II medication is one in each of the fruitful technology to decorate the drug solubility and dissolution price to decorate the bioavailability, however
cell death after transient cerebral ischemia. It belongs to the Biopharmaceutical Classification System (BCS) Class II. drugs and has pH dependent poor solubility and high permeability. The nanosuspension
Rivaroxaban is a potent selective oral direct factor Xa inhibitor, Rivaroxaban belongs to BCS Class II. Liquisolid system involves dissolving water insoluble drugs in non-volatile solvents and then converting
solubility factor remains a key concern. Now a day, many drugs especially in BCS class II and IV are observed to have less solubility. Among all solubility enhancing techniques practiced
releases of drug product in standard conditions. Telmisartan includes in the classification system BCS class (II). The angiotensin II receptors blocker of Telmisartan freely used for hypertension
preparation of solid dispersion with a poorly soluble drug. Glipizide (GPZ), a BCS class II model drug, was selected for solubility and dissolution rate study. GPZ-polymer solid dispersions
diabetes treatment. Glibenclamide is orally administered sulphonylurea anti-diabetic drug which is BCS class II drug. Aim of the study is to formulate and evaluate nano-sponges containing glibenclamide
gout, arthritis, rheumatoid arthritis and sun burn. But it has low water solubility (BCS Class II). To improve its solubility and thus permeability in or through the skin, FB nanoformulations
Oral route is the preferred route for higher patient compliance. Rosuvastatin Calcium is BCS class II drug and its oral bioavailability is 20%. To overcome this problem, studies were performed
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.